Similar companies
Did Lexicon Pharmaceuticals Beat Earnings?
Lexicon Pharmaceuticals (LXRX) reported Q2 '25 revenue of $29M, up 1,652.6% year-over-year, with reported EPS of $0.01. That topped the $-0.08 analyst estimate by 112.5% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Lexicon Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full LXRX stock analysis or the earnings calendar for upcoming reports.
Lexicon Pharmaceuticals Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.8M | 27M | 1.3M | 29M | 14M | 5.5M | 21M | 690,000 |
| Gross margin | 95.9% | 2.3% | 97.6% | 99.3% | 99.9% | 94.2% | 99.5% | 94.4% |
| Operating margin | -3,639.6% | -123.3% | -2,034.8% | 12.9% | -85.9% | -269.1% | -4.7% | -3,835.3% |
| Net income | -65M | -34M | -25M | 3.3M | -13M | -16M | -1M | -32M |
| Net margin | -3,703.5% | -127.2% | -2,004.4% | 11.3% | -90.0% | -282.7% | -4.9% | -4,591.8% |
| EPS | — | — | — | $0.01 | — | — | — | — |
Lexicon Pharmaceuticals Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Lexicon Pharmaceuticals’s quarterly revenue moved from $1.8M to $690,000. Net margin compressed from -3703.5% to -4591.8%, against a 94.4% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Lexicon Pharmaceuticals has beaten Wall Street EPS estimates in 1 of its last 1 reported quarters.
When Is Lexicon Pharmaceuticals’s Next Earnings Date?
Lexicon Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q2 '25. For the confirmed upcoming date — and every other company reporting soon — see the LXRX earnings calendar.
Frequently Asked Questions: Lexicon Pharmaceuticals Earnings
Lexicon Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Lexicon Pharmaceuticals reported Q2 '25 EPS of $0.01 on revenue of $29M (+1,652.6% YoY). Lexicon Pharmaceuticals beat estimates, reporting $0.01 vs. the $-0.08 estimate.
Lexicon Pharmaceuticals reported Q2 '25 revenue of $29M, up 1,652.6% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the LXRX AI Score.
